Drug Discovery

Polling station sign
#Association of the British Pharmaceutical Industry #Drug discovery #Medicines Discovery Catapult #UK #UK government

UK 2024 election: A vote for drug discovery

By DDW Editor Reece Armstrong The upcoming general election in the UK has placed the priorities of the country into the spotlight and the drug discovery sector should in no way be forgotten. Economic uncertainty, challenging global conditions and a healthcare system facing serious pressures, means that whatever government takes the… Read More

#Exclusive Content #Opinion

#Drug discovery #ELRIG #Events #The Protein Society

Partnership to advance protein sciences in drug discovery 

ELRIG UK has partnered with The Protein Society (TPS) to provide forums for the advancement of research into protein structure, function, design and applications.   The partners will collaborate to deliver a joint conference on ‘Protein Sciences in Drug Discovery’, bringing together their respective communities to focus on… Read More

#News

#Appointment #Career #Drug discovery #New appointment

Senior level moves within drug discovery

There have been a significant number of changes in c-level positions within the industry over the last two months. Dale Levitzke, Chief Executive Officer, and Curtis Nicholson, Director of Sales for Europe, Middle East, and Africa (EMEA), Sphere Fluidics: Levitzke brings over 25 years’ experience in… Read More

#News

Neuroscience concept
#Drug discovery #In Focus Report #Market reporting #Neuroscience

New eReport: Advances in neuroscience research

The global prevalence of dementia is approximately 24 million, and is predicted to double every 20 years until at least 2040. Currently, no medications can cure this, though 2024 has proved to be a poignant year of developments in neuroscience, especially considering the challenges faced in previous decades. This guide… Read More

#News

#Assays #Case study #Drug development #Drug discovery #iPSC #Neurology

Case Study: Consistent assays for neurological drug development

A new Case Study is now available to download for free entitled ‘Improving physiological relevance in neurological disease drug development.’ In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop… Read More

#News

Case Study: Improving physiological relevance in neurological disease drug development
#Assays #Drug development #Drug discovery #iPSC #Neurology

Improving physiological relevance in neurological disease drug development

In this case study, hear from Elise Malavasi, PhD, a Principal Scientist at leading contract research organisation Concept Life Sciences. The interview highlights their need to develop assays that are amenable to long term use to support their clients with drug development, and how bit.bio’s deterministically programmed ioMicroglia have helped… Read More

#Resources

Bacteria in Petri dishes
#Drug development #Drug discovery #eBook #Stability characterisation #Testing

New eBook: Enhance your knowledge of drug stability testing

Learn about the key principles, methodologies and regulatory requirements of drug stability testing in a new eBook from Thermo Fisher Scientific: ‘Drug Stability Testing 101‘. The eBook has been prepared by scientists and industry professionals to provide readers with valuable insights and practical knowledge to help optimise… Read More

#News

Drug stability testing eBook
#Drug development #Drug discovery #Stability characterisation #Testing

Drug Stability Testing 101

Learn about the key principles, methodologies and regulatory requirements of drug stability testing with our recently developed eBook: ‘Drug Stability Testing 101’. This eBook has been prepared by scientists and industry professionals at Thermo Fisher Scientific to provide you with valuable insights and practical knowledge to help you optimise this critical… Read More

#Resources

#Drug discovery #Immunology / Virology & Vaccines

Webinar: Innovative strategies for residual DNA and viral titre quantitation using dPCR – supported by Thermo Fisher Scientific 20.06.2024

Leveraging digital PCR-based assays for the quantitation of residual host cell DNA or viral titres within a biotherapeutic manufacturing workflow offers significant value in ensuring product quality and safety. Digital PCR, or dPCR, is a highly sensitive and precise technique that enables the absolute quantification of nucleic acid targets.  In… Read More

#Webinars

Therapeutic antibodies
#Antibody drug conjugate (ADC) #Bispecific Antibodies #Drug discovery #eBook #Therapeutic Antibodies

eBook: The impact of therapeutic antibody discovery

A new eBook, sponsored by Sino Biological, is now available for download entitled ‘The impact of therapeutic antibody discovery’. The first monoclonal antibody (mAb), Orthoclone, was approved in 1986 to help prevent rejection in organ transplantation. Since then, the US Food and Drug… Read More

#News

#Drug discovery

Webinar: From patient to petri dish: Replicating disease with patient-derived organoids – supported by HUB Organoids – 18.06.2024

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models. These models often fail to accurately represent the intricate biology of human patients.  This webinar explores how patient-derived organoids (HUB Organoids) are revolutionising drug discovery by overcoming these challenges. Read More

#Webinars

Cancer cells
#Cancer #Drug discovery #Oncology #Radioligand Therapies (RLTs)

How ready are we for radioligand therapies?  

DDW Editor Reece Armstrong speaks to Jasminka Taleska, Director, RLT HCS Readiness and Policy at Novartis, about the opportunities radioligand therapies (RLTs) represent in treating cancer patients.   RA: What are the potentials of RLTs across cancer?  JT: Cancer is an incredibly complex and… Read More

#Cancer Research #Exclusive Content

#Biotech #Drug discovery #Funding #Investment #UK

Early-stage biotech investment: where are we? 

Yogan A Patel, Partner at MHA and Head of MHA’s Pharma, Life Science and Med-Tech sector group examines the investment landscape for early-stage biotech companies in the UK and further afield.   It is well recognised by both investors and government that the UK has… Read More

#Exclusive Content

#Artificial intelligence (AI) #Automation / robotics #Lab automation #Lab technology

Publication provides a roadmap for laboratory robotics in Europe

The Analytical Laboratory Robotics Topic group of euRobotics has released the next iteration of the roadmap for Analytical Laboratory Robotics in Europe. It is entitled ‘Research roadmap for laboratory community-automating discovery: high throughput experimentation, diagnostics and robotics/AI’. The roadmap will be formally launched during… Read More

#News

#Drug discovery

eBook: Enhance your knowledge of drug stability testing

Learn about the key principles, methodologies and regulatory requirements of drug stability testing with our recently developed eBook: Drug Stability Testing 101. This eBook has been prepared by scientists and industry professionals at Thermo Fisher Scientific to provide you with valuable insights and practical knowledge to help you optimise… Read More

#eBooks

Bone marrow organoids
#Drug discovery #Human disease models #Organoids #Preclinical development #Webinar

Are organoids superior to other preclinical models?

Developing new drugs is a complex and often lengthy process. A major roadblock lies in the limitations of traditional preclinical models, which often fail to accurately represent the intricate biology of human patients. Join DDW for a free event on 18 June, 3PM… Read More

Webinar date:
Supported by HUB Organoids
#News